Brown M Rowan, Hondow Nicole, Brydson Rik, Rees Paul, Brown Andrew P, Summers Huw D
College of Engineering, Swansea University, Swansea, SA2 8PP, UK.
Nanotechnology. 2015 Apr 17;26(15):155101. doi: 10.1088/0957-4484/26/15/155101. Epub 2015 Mar 23.
The application of nanoparticles (NPs) within medicine is of great interest; their innate physicochemical characteristics provide the potential to enhance current technology, diagnostics and therapeutics. Recently a number of NP-based diagnostic and therapeutic agents have been developed for treatment of various diseases, where judicious surface functionalization is exploited to increase efficacy of administered therapeutic dose. However, quantification of heterogeneity associated with absolute dose of a nanotherapeutic (NP number), how this is trafficked across biological barriers has proven difficult to achieve. The main issue being the quantitative assessment of NP number at the spatial scale of the individual NP, data which is essential for the continued growth and development of the next generation of nanotherapeutics. Recent advances in sample preparation and the imaging fidelity of transmission electron microscopy (TEM) platforms provide information at the required spatial scale, where individual NPs can be individually identified. High spatial resolution however reduces the sample frequency and as a result dynamic biological features or processes become opaque. However, the combination of TEM data with appropriate probabilistic models provide a means to extract biophysical information that imaging alone cannot. Previously, we demonstrated that limited cell sampling via TEM can be statistically coupled to large population flow cytometry measurements to quantify exact NP dose. Here we extended this concept to link TEM measurements of NP agglomerates in cell culture media to that encapsulated within vesicles in human osteosarcoma cells. By construction and validation of a data-driven transfer function, we are able to investigate the dynamic properties of NP agglomeration through endocytosis. In particular, we statistically predict how NP agglomerates may traverse a biological barrier, detailing inter-agglomerate merging events providing the basis for predictive modelling of nanopharmacology.
纳米颗粒(NPs)在医学中的应用备受关注;其固有的物理化学特性为改进现有技术、诊断方法和治疗手段提供了潜力。最近,已开发出多种基于纳米颗粒的诊断和治疗剂用于治疗各种疾病,其中巧妙地利用表面功能化来提高给药治疗剂量的疗效。然而,与纳米治疗剂绝对剂量(纳米颗粒数量)相关的异质性定量,以及其如何跨越生物屏障进行运输,已证明难以实现。主要问题在于在单个纳米颗粒的空间尺度上对纳米颗粒数量进行定量评估,而这些数据对于下一代纳米治疗剂的持续发展至关重要。样品制备和透射电子显微镜(TEM)平台成像保真度方面的最新进展提供了所需空间尺度的信息,在此尺度下可以单独识别单个纳米颗粒。然而,高空间分辨率会降低样品频率,结果动态生物学特征或过程变得不清晰。但是,将TEM数据与适当的概率模型相结合提供了一种提取单独成像无法获得的生物物理信息的方法。此前,我们证明通过TEM进行的有限细胞采样可以与大量群体流式细胞术测量进行统计关联,以量化确切的纳米颗粒剂量。在此,我们将这一概念扩展,将细胞培养基中纳米颗粒聚集体的TEM测量与人类骨肉瘤细胞内囊泡包裹的纳米颗粒测量联系起来。通过构建和验证数据驱动的传递函数,我们能够研究通过内吞作用的纳米颗粒聚集的动态特性。特别是,我们从统计学上预测纳米颗粒聚集体如何穿越生物屏障,详细描述聚集体间的合并事件,为纳米药理学的预测建模提供基础。